Prenatal and neonatal exposure to perfluorooctane sulfonic acid results in aberrant changes in miRNA expression profile and levels in developing rat livers

被引:33
作者
Wang, Fan [1 ,2 ]
Liu, Wei [1 ]
Jin, Yihe [1 ]
Wang, Faqi [1 ]
Ma, Junsheng [1 ]
机构
[1] Dalian Univ Technol, Key Lab Ind Ecol & Environm Engn, MOE, Sch Environm Sci & Technol, Dalian 116024, Peoples R China
[2] Luoyang Normal Univ, Dept Biol Sci, Luoyang 471022, Peoples R China
基金
中国国家自然科学基金;
关键词
PFOS; carcinogenesis; developmental toxicity; microarray; microRNA; PERFLUOROALKYL ACIDS; DOWN-REGULATION; LUNG-CANCER; MICRORNAS; INVASION; PROLIFERATION; TOXICITY; ALPHA; PFOS; LOOP;
D O I
10.1002/tox.21949
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Perfluorooctane sulfonate (PFOS) is an animal carcinogen. However, the underlying mechanism in cancer initiation is still largely unknown. Recently identified microRNAs (miRNAs) may play an important role in toxicant exposure and in the process of toxicant-induced tumorigenesis. We used PFOS to investigate PFOS-induced changes in miRNA expression in developing rat liver and the potential mechanism of PFOS-induced toxic action. Dams received 3.2 mg/kg PFOS in their feed from gestational day 1 (GD1) to postnatal day 7 (PND 7). Pups then had free access to treated feed until PND 7. We isolated RNAs from liver tissues on PND 1 and 7 and analyzed the expression profiles of 387 known rat miRNAs using microarray technology. PFOS exposure induced significant changes in miRNA expression profiles. Forty-six miRNAs had significant expression alterations on PND 1, nine miRNAs on PND 7. Specifically, expression of four miRNAs was up-regulated on PND 7 but down-regulated on PND1 (p<0.05). Many aberrantly expressed miRNAs were related to various cancers. We found oncogenic and tumor-suppressing miRNAs, which included miR-19b, miR-21*, miR-17-3p, miR-125a-3p, miR-16, miR-26a, miR-1, miR-200c, and miR-451. In addition, four miRNAs were simultaneous significantly expressed on both PND 1 and 7. Functional Annotation analysis of the predicted transcript targets revealed that PFOS exposure potentially alters pathways associated with different cancers (cancer, melanoma, pancreatic cancer, colorectal cancer, and glioma), biological processes which include positive regulation of apoptosis and cell proliferation. Results showed PFOS exposure altered the expression of a suite of miRNAs. (c) 2014 Wiley Periodicals, Inc. Environ Toxicol 30: 712-723, 2015.
引用
收藏
页码:712 / 723
页数:12
相关论文
共 51 条
[1]   The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-α (ERα) and represses ERα messenger RNA and protein expression in breast cancer cell lines [J].
Adams, Brian D. ;
Furneaux, Henry ;
White, Bruce A. .
MOLECULAR ENDOCRINOLOGY, 2007, 21 (05) :1132-1147
[2]   Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers [J].
Alexander, Bruce H. ;
Olsen, Geary W. .
ANNALS OF EPIDEMIOLOGY, 2007, 17 (06) :471-478
[3]  
Alexander J, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.653
[4]  
[Anonymous], 2002, ENVJMRD200217FINAL O
[5]  
[Anonymous], TOXICOLOGIST
[6]  
[Anonymous], DRAFT RISK ASS POT H
[7]   Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth [J].
Apelberg, Benjamin J. ;
Witter, Frank R. ;
Herbstman, Julie B. ;
Calafat, Antonia M. ;
Halden, Rolf U. ;
Needham, Larry L. ;
Goldman, Lynn R. .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2007, 115 (11) :1670-1676
[8]   miRNA control of tumor cell invasion and metastasis [J].
Baranwal, Somesh ;
Alahari, Suresh K. .
INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (06) :1283-1290
[9]   MicroRNAs modulate the chemosensitivity of tumor cells [J].
Blower, Paul E. ;
Chung, Ji-Hyun ;
Verducci, Joseph S. ;
Lin, Shili ;
Park, Jong-Kook ;
Dai, Zunyan ;
Liu, Chang-Gong ;
Schmittgen, Thomas D. ;
Reinhold, William C. ;
Croce, Carlo M. ;
Weinstein, John N. ;
Sadee, Wolfgang .
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (01) :1-9
[10]   Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J].
Calin, GA ;
Dumitru, CD ;
Shimizu, M ;
Bichi, R ;
Zupo, S ;
Noch, E ;
Aldler, H ;
Rattan, S ;
Keating, M ;
Rai, K ;
Rassenti, L ;
Kipps, T ;
Negrini, M ;
Bullrich, F ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15524-15529